To determine how the National Comprehensive Cancer Network (NCCN) guidelines for tamoxifen and aromatase inhibitors (AIs) can be adapted to address the symptom burden for women with breast cancer in the follow up phase of treatment, who are receiving care in the North East of Ireland

No summary available


Award Date
20 October 2016
Award Value
Principal Investigator
Ms Elizabeth Summersby
Host Institution
University College Dublin
Project Development Grants